Please login to the form below

Not currently logged in
Email:
Password:

Pharma market access [infographic]

A 12 step process for preparing a pharma brand for market

Pharma market access infographic

There is no 'one' definition of market access – the idea of which varies from company to company; region to region.

But while there may not be consensus on the exact wording – which spans everything from 'stakeholders' to 'accelerate market uptake', 'optimising value' and 'pricing and reimbursement' – most agree that it is not a 'discipline' that can be packaged neatly into a silo.

Inside: Market Access, a new publication from PMLiVE's publishers PMGroup, provides expert thinking on the area and includes a unique market access road map.

Download full size infographic on 12 steps to prepare a pharma brand for market (pdf - right click and select 'save link as')

Pharma market access reportThe publication, which PME subscribers received earlier this month, also looks at:

• Re-positioning pharma's image for market access success
• How to equip market access teams for local challenges
• The role of communication and education
• The true meaning of market access
• UK market access and the NHS
• How NICE is collaborating, and exporting its thinking, across Europe and beyond
• EU pricing and reimbursement, and reference pricing.

View Inside: Market Access online

28th June 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics